SciELO - Scientific Electronic Library Online

 
vol.65 issue3Primary cutaneous melanoma: an 18-year studyIntra-arterial blood pressure response in hypertensive subjects during low- and high-intensity resistance exercise author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Clinics

Print version ISSN 1807-5932

Abstract

PESARO, Antonio Eduardo et al. Effect of β-blockers on the risk of atrial fibrillation in patients with acute myocardial infarction. Clinics [online]. 2010, vol.65, n.3, pp. 265-270. ISSN 1807-5932.  http://dx.doi.org/10.1590/S1807-59322010000300005.

INTRODUCTION: Oral β-blockers improve the prognosis of patients with acute myocardial infarction, while atrial fibrillation worsens the prognosis of this population. The reduction of atrial fibrillation incidence in patients treated with β-blockers could at least in part explain the benefits of this drug. OBJECTIVE: To investigate the effect of β-blockers on the incidence of atrial fibrillation in patients with acute myocardial infarction. METHODS: We analyzed 1401 patients with acute myocardial infarction and evaluated the occurrence or absence of atrial fibrillation, the use of oral β-blockers and mortality during the first 24 hours. RESULTS: a) The use of β-blockers was inversely correlated with the presence of atrial fibrillation (ρ = 0.004; OR = 0.54). b) Correlations with mortality were as follows: 31.5% in patients with atrial fibrillation, 9.2% in those without atrial fibrillation (ρ < 0.001; Odds Ratio = 4.52), and 17.5% in patients not treated with β-blockers and 6.7% in those who received the drug (ρ < 0.001; OR = 0.34). c) Adjusted Models: The presence of atrial fibrillation was independently correlated with mortality (OR = 2.48, ρ = 0.002). The use of β-blockers was inversely and independently correlated with mortality (OR = 0.53; ρ = 0.002). The patients who used β-blockers showed a lower risk of atrial fibrillation (OR = 0.59; ρ = 0.029) in the adjusted model. CONCLUSION: The presence of atrial fibrillation and the absence of oral β-blockers increased in-hospital mortality in patients with acute myocardial infarction. Oral β-blockers reduced the incidence of atrial fibrillation, which might be at least partially responsible for the drug's benefit.

Keywords : Acute myocardial infarction; β-blockers; Atrial fibrillation; Mortality; Arrhythmias.

        · text in English     · pdf in English